Local cover image
Local cover image
Image from Google Jackets

Design and characterization of ph dependent phase transition system of almotriptan malate for nasal drug delivery system by employing factorial design

By: Contributor(s): Publication details: Bangalore Association of Pharmaceutical Teachers of India (APTI) 2024Edition: Vol.58(1), Jan-MarDescription: 76-90pSubject(s): Online resources: In: Indian journal of pharmaceutical education and researchSummary: Introduction: Nasal medication delivery uses nasal mucosa for faster and higher drug absorption. Transmucosal nasal administration is promising. Many medicines obtain superior systemic absorption via nasal route than orally. Objectives: This research aimed to construct and characterize a pH-dependent almotriptan malate nasal in situ gel for acute migraine treatment. It eases discomfort, headaches, and migraine symptoms. Materials and Methods: Gels were delivered by changing the grouping of pH-sensitive and mucoadhesive polymers, explicitly HPMC-E15 and chitosan hydrochloride, in a cycle that was done by applying cool method Results. The range of drug content was between 95.87±0.45 to 99.58±0.56%. The pH value was measured to fall between 6.10±0.92 and 6.41±0.11. The obtained results notably agreed with the change in phase+transition, and the formulations portraits the rheology in a pseudoplastic behavior. This was a very exciting discovery. The mucoadhesiveness of all of the formulations rose with the HPMC-E15: Chitosan HCl concentration which was found to be in the range of 2133±1.58 to 3111.47±1.32 dynes/cm2 for the most effective formulations. The in vitro release of drug results of the optimized formulation, which consisted of 5 g HPMC-E15, 1 g Chitosan hydrochloride, and 1.5 g PEG400, indicated that 94.24±0.96% release occurred at the end of 12 hr. Studies using histopathology indicated that the AMF4 formulation had a non-toxic effect on the microscopic structure of the nasal mucosa when it was subjected to ex vivo permeation tests which showed the drug release of 78.85±0.87 %. Based on the findings of the stability research, a temperature range of 5ºC±3ºC is recommended for storing the formulations. Conclusion: As per these discoveries, nasal in situ gel containing almotriptan malate is probably going to turn into a selection of arrangements for treating migraines and other symptoms associated with migraines in the near future and in a nutshell, an in situ gel formulation of almotriptan malate that is pH dependent has the potential to function as an efficient method of treating migraines.
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Status Barcode
Articles Abstract Database Articles Abstract Database School of Pharmacy Archieval Section Not for loan 2025-1222
Total holds: 0

Introduction: Nasal medication delivery uses nasal mucosa for faster and higher drug absorption. Transmucosal nasal administration is promising. Many medicines obtain superior systemic absorption via nasal route than orally. Objectives: This research aimed to construct and characterize a pH-dependent almotriptan malate nasal in situ gel for acute migraine treatment. It eases discomfort, headaches, and migraine symptoms. Materials and Methods: Gels were delivered by changing the grouping of pH-sensitive and mucoadhesive polymers, explicitly HPMC-E15 and chitosan hydrochloride, in a cycle that was done by applying cool method Results. The range of drug content was between 95.87±0.45 to 99.58±0.56%. The pH value was measured to fall between 6.10±0.92 and 6.41±0.11. The obtained results notably agreed with the change in phase+transition, and the formulations portraits the rheology in a pseudoplastic behavior. This was a very exciting discovery. The mucoadhesiveness of all of the formulations rose with the HPMC-E15: Chitosan HCl concentration which was found to be in the range of 2133±1.58 to 3111.47±1.32 dynes/cm2 for the most effective formulations. The in vitro release of drug results of the optimized formulation, which consisted of 5 g HPMC-E15, 1 g Chitosan hydrochloride, and 1.5 g PEG400, indicated that 94.24±0.96% release occurred at the end of 12 hr. Studies using histopathology indicated that the AMF4 formulation had a non-toxic effect on the microscopic structure of the nasal mucosa when it was subjected to ex vivo permeation tests which showed the drug release of 78.85±0.87 %. Based on the findings of the stability research, a temperature range of 5ºC±3ºC is recommended for storing the formulations. Conclusion: As per these discoveries, nasal in situ gel containing almotriptan malate is probably going to turn into a selection of arrangements for treating migraines and other symptoms associated with migraines in the near future and in a nutshell, an in situ gel formulation of almotriptan malate that is pH dependent has the potential to function as an efficient method of treating migraines.

There are no comments on this title.

to post a comment.

Click on an image to view it in the image viewer

Local cover image
Share
Unique Visitors hit counter Total Page Views free counter
Implemented and Maintained by AIKTC-KRRC (Central Library).
For any Suggestions/Query Contact to library or Email: librarian@aiktc.ac.in | Ph:+91 22 27481247
Website/OPAC best viewed in Mozilla Browser in 1366X768 Resolution.